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I. Introduction 
Magnetic resonance renography (MRR) has been sug-
gested as an alternative to radioisotope renography (RR) for 
estimating differential, and possibly absolute, renal function. 
The injection of DTPA, a pure glomerular filtrate, tagged to a 
technetium isotope (99mTc) in the case of RR and to gadolini-
um (Gd) in the case of MR, allows renography to be under-
taken. Data is acquired as a function of time and the distribu-
tion of the DTPA in the kidney reflects different aspects of 
renal function depending on the time-frame selected for anal-
ysis. While MRR has the same basis as RR, advantages of 
MRR compared to RR include the lack of ionising radiation, 
increased spatial resolution and availability of volumetric 
data that contains both tracer kinetics and anatomical infor-
mation. These advantages make MRR an attractive alterna-
tive to RR, especially in paediatric cases. 
 
   
Figure 1: Abdominal image of a patient (single kidney) using a 
gamma camera showing Tc-DTPA renal uptake (left). Contrast-
enhanced abdominal image of a volunteer using dynamic MR 
(middle). Anatomical high-resolution scan using MR (right).  
 
To date, MRR and, even RR techniques have failed to 
robustly estimate absolute glomerular filtration rate (GFR) 
when compared to ‘gold standard’ plasma-sampling methods 
using 51Cr-EDTA or inulin clearance (1). Prior work has 
identified various factors that need to be considered for 
accurate quantification of glomerular filtration rate on MRR. 
These include kidney movement artefacts (2), the selection of 
a suitable region of interest (ROI) for the analysis  (3), non-
linear relationship between signal intensity and gadolinium 
concentration (4) and suitability of the models used to 
estimate GFR (5). 
 Whilst all the aforementioned aspects are recognised as 
confounding factors on GFR quantification, there has, until 
now, been no consideration of the partial volume effect 
(PVE) in MRR in the published literature. The PVE occurs 
where the signals from two or more tissues combine to pro-
duce a single image intensity value within a particular voxel. 
This is a result of the finite bandwidth of the image acquisi-
tion system, occurring mostly at the boundaries between tis-
sues, and is present to a greater or lesser degree in all imag-
ing modalities. Currently, ROI selection for subsequent GFR 
estimation relies on conventional segmentation (a mutually-
exclusive binary decision on whether a particular voxel be-
longs to a particular tissue class). In contrast, PV analysis 
assigns a set of mixing values to each voxel, corresponding 
to the fractional signal component from various adjacent tis-
sue structures that contribute to the observed signal intensity. 
Whilst there is significant interest in PVs for image quantifi-
cation of MR brain data, PV quantification techniques have 
yet to be investigated for MRR.  
 In this study we investigate the PVE of adjacent tissues 
on the renal cortical MRI signal and its influence on GFR 
quantification. Further we propose a methodology for MRR 
based on an initial movement correction step, followed by 
PVE correction, and Rutland-Patlak analysis of a cortical 
ROI to estimate renal function. 
 
II. Material and Methods 
Data Acquisition 
 
Oblique-coronal contrast enhanced dynamic data vol-
umes from a healthy volunteer with normal renal function 
were acquired on a 1.5T Siemens Avanto scanner using a 
SPGR 3D-FLASH pulse-sequence (VIBE): TE/TR = 
0.53/1.63 ms, flip angle = 17, acquisition matrix = 128x104 
voxels, 400x325 mm FOV. The dynamic dataset consisted of 
a sequence of 3D volumes with 18 slices of 7.5mm thickness 
(no gap) and an in-plane voxel dimension of 3.1x3.1 mm, 
acquired every 2.5 s for several minutes. The injected Gd-
DTPA dose was 0.05 mmol/kg body weight, injected as a 
bolus at 2ml/second using an automatic injector (Spectris). 
The contrast agent bolus was immediately followed by a 15 
ml saline flush injected at the same speed. 
In addition to the dynamic data, an anatomical high-
resolution scan was acquired during breath-hold before con-
trast enhancement using a true-FISP sequence: TE/TR = 
1.67/3.34 ms, flip angle = 68, acquisition matrix = 256x187 
voxels, 400x325 mm FOV. The high-resolution anatomical 
data consisted of a 3D volume with 18 slices of 7.5mm 
thickness (no gap) and an in-plane voxel dimension of 
1.56x1.56 mm. The high resolution data are used to create 
patient-specific templates minimally affected by PVEs and 
thus representing true object boundaries.  It is on these tem-
plates that the blurring effects of the dynamic acquisition 
sequence are investigated, by modelling its Point Spread 
Function (PSF). 
 
Image Processing and Analysis 
 
PSF Estimation: The 3D PSF of the dynamic sequence was 
obtained from Line Spread Functions estimated by differenti-
ating edge profiles of phantom data at multiple orientations 
using the above dynamic acquisition sequence. 
 
Movement Correction: Data were corrected using the 2D 
movement correction technique described in (6). 
  
PV correction: The proposed approach is based on estima-
tion of the mixing between different tissues within every 
voxel, and the definition of observed time-intensity curves as 
   
  
the sum of individual time-intensity curves that correspond to 
each tissue class. 
Assuming linear mixing, the problem of partial volumes 
might be though of as that of finding for every voxel a 
mixing vector, α:  
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where n is the number of tissues present in the voxel. Thus, 
the mixing vector represents the percentage of each tissue 
captured within that voxel. This template-based approach is 
similar to that used in PET/SPECT, often referred to as the 
geometric transfer matrix (7). However, in contrast to using 
PET/SPECT with MR/CT, our approach to generating the 
mixing vectors consists of acquiring a higher resolution 
anatomical MRI volume, prior to contrast injection that is 
then segmented to produce noiseless high resolution binary 
tissue templates. Assuming linear mixing, these high 
resolution templates are then individually filtered, using the 
PSF of the sequence used during dynamic contrast-enhanced 
acquisition and down-sampled to the same dimensions of the 
dynamic data. Thus, the individual components (αk) of the 
mixing vector for each voxel are generated (see Figure 2 
below).  
    
Figure 2: High resolution image and segmentation of liver and right 
kidney (left) and α-map corresponding to the right kidney (right). 
Having obtained the corresponding α-maps for each 
pixel, the observed intensity Iobs for each voxel within or 
surrounding the kidney can be defined as: 
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Knowing Iobs and the α-maps, the above equation can be 
solved for the signal intensity curves of individual tissue 
components, provided there are more than n observations per 
ROI. 
Rutland-Patlak Analysis: Finally, the Rutland-Patlak (8) 
approach is used to produce filtration estimates on a cortical 
ROI, RROI. Assuming unilateral flow from the arterial to the 
renal space and that no tracer leaves the RROI, filtration might 
be estimated from plotting the following straight-line 
equation: 
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where AROI(τ) is an arterial ROI, normally placed on the 
aorta. Using Rutland-Patlak analysis between one and two 
minutes after tracer injection, k1 is then an estimate of GFR.  
 
III. Results 
Preliminary results on a cortical region close to the liver, 
as an example on how to eliminate the contributions from the 
liver and fat surrounding the right kidney from the renal 
signal-intensity curve are presented. 
Figure 3 shows a cortical ROI selected from voxels 
inside the kidney that are also affected by liver and fat partial 
volumes (PVs). The graph shows time-intensity curves for 
the ROI both before and after PV correction. The corrected 
renal curve clearly shows an increased slope on the filtration 
phase. The effect of this correction is clearly shown in Figure 
4 where the Rutland-Patlak plot estimates of per-pixel 
filtration are twice those of the raw data.  
 
Figure 3: Cortical ROI (inside yellow contour) overlaid on to the 
dynamic data (insert) and corresponding time-intensity curves: raw 
data (green) and corrected renal (blue). 
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Figure 4: Rutland-Patlak plot of the filtration phase of the raw and 
PV-corrected time-intensity curves from the ROI shown in Figure 3. 
 
IV. Conclusion 
We have presented a methodology for GFR estimation 
based on movement and partial volume correction followed 
by Patlak analysis. The effects of PVE correction in filtration 
estimates have been shown to be significant and must be 
considered in the development of MRR techniques suitable 
for estimating GFR. Further work is being directed towards 
correction of PV effects from tissues within the kidney not 
involved in the filtration phase. 
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